Cargando…
TORC1 INHIBITION AS AN IMMUNOTHERAPY TO DECREASE INFECTIONS IN THE ELDERLY
Inhibition of TORC1 has extended lifespan in multiple preclinical species. Thus drugs inhibiting TORC1 may have therapeutic benefit for aging-related conditions in humans. An aging-related condition that improves with TORC1 inhibition in old mice is immunosenescence (the aging-related decline in imm...
Autor principal: | Mannick, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6845614/ http://dx.doi.org/10.1093/geroni/igz038.2988 |
Ejemplares similares
-
CLINICAL TRIALS IN GEROSCIENCE
por: Kaeberlein, Matt, et al.
Publicado: (2019) -
AGING TREATMENT BY COUNTERACTING INTRINSIC DNA DAMAGE AND IMMUNOSENESCENCE
por: Gudkov, Andrei
Publicado: (2019) -
AGING INTERVENTIONS GET HUMAN: CAN WE EXTEND HEALTHSPAN?
por: Kennedy, Brian
Publicado: (2019) -
CELLULAR SENESCENCE AS A THERAPEUTIC TARGET FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019) -
LB2. TORC1 Inhibition with RTB101 as a Potential Pan-Antiviral Immunotherapy to Decrease the Incidence of Respiratory Tract Infections Due to Multiple Respiratory Viruses in Older Adults
por: Mannick, Joan, et al.
Publicado: (2019)